Your browser doesn't support javascript.
loading
Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641).
Ai, Xinghao; Cui, Jiuwei; Zhang, Jiexia; Chen, Rongrong; Lin, Wen; Xie, Congying; Liu, Anwen; Zhang, Junping; Yang, Weihua; Hu, Xiaohua; Hu, Xiaohua; Zhao, Qiong; Rao, Chuangzhou; Zang, Yuan-Sheng; Ning, Ruiling; Li, Pansong; Chang, Lianpeng; Yi, Xin; Lu, Shun.
Afiliação
  • Ai X; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, P.R. China.
  • Cui J; Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, P.R. China.
  • Zhang J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, P.R. China.
  • Chen R; GenePlus-Beijing, Beijing, P.R. China.
  • Lin W; Cancer Hospital of Shantou University Medical College, Shantou, P.R. China.
  • Xie C; Department of Radiotherapy and Chemotherapy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Liu A; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, P.R. China.
  • Zhang J; Department of Cancer Biotherapy, Shanxi Academy of Medical Sciences (Shanxi Dayi Hospital, Shanxi Bethune Hospital), Taiyuan, P.R. China.
  • Yang W; Department of Respiratory, Shanxi Tumor Hospital, Taiyuan, P.R. China.
  • Hu X; Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China.
  • Hu X; Department of Oncology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China.
  • Zhao Q; Department of Thoracic Oncology, Shulan Hangzhou Hospital, Affiliated Shulan International Medical College of Zhejiang Shuren University, Hangzhou, P.R. China.
  • Rao C; Department of Radiotherapy & Chemotherapy, Ningbo, Ningbo No. 2 Hospital, P.R. China.
  • Zang YS; Department of Medical Oncology, Changzheng Hospital, Navy Military Medical University, Shanghai, P.R. China.
  • Ning R; Department of Medical Oncology of Respiratory, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, P.R. China.
  • Li P; GenePlus-Beijing, Beijing, P.R. China.
  • Chang L; GenePlus-Beijing, Beijing, P.R. China.
  • Yi X; GenePlus-Beijing, Beijing, P.R. China.
  • Lu S; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, P.R. China. shunlu@sjtu.edu.cn.
Clin Cancer Res ; 27(3): 704-712, 2021 02 01.
Article em En | MEDLINE | ID: mdl-33188140
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article